A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.

NCT07185243 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: recombinant human IL-21-expressing oncolytic vaccinia virus injection

Sponsor

Hangzhou Converd Co., Ltd.

Collaborators

[object Object]